Countdown of Alexion, developer of Soliris, to enter the domestic market

Another global pharmaceutical company is confirmed to consider a market entry to Korea.

The company is Alexion Pharmaceuticals, domestically well-known as a developing company of ‘Soliris, a PNH(paroxysmal nocturnal hemoglobinuria) therapy.

According to the industry concerned on the 25^th, the company dispatched its personnel from the headquarters from the 2^nd half of the last year and has wor...